Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) a Buy, Sell, or Hold?
NASDAQ : FTXH
First Trust Nasdaq Pharmaceuticals ETF
$39.9811 USD
$0.07 (0.18%)
- Volume
- 0
- Average Volume
- 561.73K
- Market Capitalization
- $989.49M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $42.87
- Year Low
- $27.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
NASDAQ
Asset Management - Global
Financial Services
FTXH
N/A
US
USD
1-800-621-1675
33738R837
0001552740
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
No executive data available.
Poll Results
No votes yet today — be the first to share your view!
About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%. ...
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now?
2026-08-06 07:21:12
The First Trust NASDAQ Pharmaceuticals ETF (FTXH) was launched on 09/20/2016, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
2026-07-30 07:21:07
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the First Trust NASDAQ Pharmaceuticals ETF (FTXH) is a passively managed exchange traded fund launched on September 20, 2016.
Trump to announce discount drug pricing expansion, White House official says
2026-05-18 12:47:12
U.S. President Donald Trump will announce a dramatic expansion of TrumpRx.gov, a government-backed website offering discounted prescription drugs under his administration's pricing deal, on Monday, a White House official said.
Frequently Asked Questions
-
What is the current First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock price?
-
First Trust Nasdaq Pharmaceuticals ETF(NASDAQ:FTXH) stock price is $39.9811 in the last trading session. During the trading session, FTXH stock reached the peak price of $42.87 while $26.998 was the lowest point it dropped to. The percentage change in FTXH stock occurred in the recent session was 0.18% while the dollar amount for the price change in FTXH stock was $0.07.
-
FTXH's industry and sector of operation?
-
The NASDAQ listed FTXH is part of Asset Management - Global industry that operates in the broader Financial Services sector.
-
Who are the executives of FTXH?
-
|
|
|
|
| -
How many employees does FTXH have?
-
Number of FTXH employees currently stands at None. FTXH operates from 120 East Liberty Drive, Suite 400, Wheaton, IL 60187, US.
-
Link for FTXH official website?
-
Official Website of FTXH is: https://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH
-
How do I contact FTXH?
-
FTXH could be contacted at phone #1-800-621-1675 and can also be accessed through its website. FTXH operates from 120 East Liberty Drive, Suite 400, Wheaton, IL 60187, US.
-
How many shares of FTXH are traded daily?
-
The average number of FTXH shares traded daily for last 3 months was 561.73K.
-
What is the market cap of FTXH currently?
-
The market value of FTXH currently stands at $989.49M with its latest stock price at $39.9811